Instituto de Medicina Regenerativa
3 clinical trials · Sponsor
◉ Watch Instituto de Medicina Regenerativa
| Record | Firm | Date |
|---|---|---|
| Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms (NCT05475106) | Instituto de Medicina Regenerativa | 2022-05-12 |
| Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms (NCT04509167) | Instituto de Medicina Regenerativa | 2020-08-10 |
| Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19 (NCT04456361) | Instituto de Medicina Regenerativa | 2020-04-16 |
Track Instituto de Medicina Regenerativa automatically
Every clearance here is in the API, with alerts when new ones post.